Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindu.com - The Hindu Bureau - FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot
FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot
The Hindu

The Karnataka Food Safety and Drugs Administration (FSDA) has cancelled the licences of 16 pharmaceutical retailers and wholesalers and suspended those of eight others, including the licence of multinational firm Pfizer's depot in Nelamangala, in…

thehindubusinessline.com - India's biotech start-ups need patient capital to drive novel drug innovation, industry leaders say
India's biotech start-ups need patient capital to drive novel drug innovation, industry leaders say
BusinessLine

India's biotech start-ups need larger and more patient pools of capital to take novel drug candidates through the long and high-risk development cycle, while stronger links between academia, investors and industry are needed to build a domestic…

indianexpress.com - IE Online - Pacemakers to syringes: Why India needs fair pricing for medical devices
Pacemakers to syringes: Why India needs fair pricing for medical devices
The Indian Express

When Maharashtra FDA (Food and Drug Administration) Commissioner Tukaram Munde recently flagged the exploitative margins in medical devices, he echoed what patients, policymakers and industry have long known: India urgently needs a distinct…

marketbeat.com - Top Growth Stocks To Watch Now - September 20th
Top Growth Stocks To Watch Now - September 20th
MarketBeat

Could Falling Yields Make REIT Stocks Worth a Second Look? Prologis, Ascendis Pharma A/S, Teledyne Technologies, Jersey Mike's, Pershing Square, Pattern Group, and Hamilton Lane are the seven Growth stocks to watch today, according to MarketBeat's…

zerohedge.com - Tyler Durden - Keep Digging'... Says Shovel-Salesman Jensen Huang
Keep Digging'... Says Shovel-Salesman Jensen Huang
Zero Hedge

Maybe it's the bullshit detection genes that were passed down to me from my mother, but I simply can't wind up trusting a word Nvidia CEO Jensen Huang says about how much AI regulation the United States needs. Just call it a gut reaction from me.

indianexpress.com - Manish Sahu - Staged kidnapping backfires: UP Police uncover 'university' operating from farm
Staged kidnapping backfires: UP Police uncover 'university' operating from farm
The Indian Express

4 min read Lucknow Make us preferred source on Google What started as a made-up kidnapping story in Uttar Pradesh ‘s Etah has instead exposed a four-year-old fake university and college scam, one that allegedly churned out bogus degrees from…

itnews.com.au - Anthropic quietly sets up biology lab
Anthropic quietly sets up biology lab
iTnews

Anthropic has quietly set up a laboratory to do physical biology work as it pushes its artificial-intelligence ambitions into the world of drug ⁠science. At a time when ⁠fears of AI are gripping the public, the startup has built a wet…

dailymail.com - James Reinl - Fears as new drug 10 TIMES stronger than fentanyl spreads across US
Fears as new drug 10 TIMES stronger than fentanyl spreads across US
Mail Online

When Christina Lacourte found her 16-year-old son Dante unresponsive in their San Francisco apartment in April, she grabbed two doses of Narcan from the kitchen and gave him both. The drug that killed Dante – cychlorphine, a synthetic opioid…

marketbeat.com - Cybin Eyes Q4 Phase III Depression Readout as Psychedelic Pipeline Advances
Cybin Eyes Q4 Phase III Depression Readout as Psychedelic Pipeline Advances
MarketBeat

Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise Helus Pharma Chief Executive Officer Michael Halstead said the company expects a pivotal Phase III readout for its HLP003 program in adjunctive major depressive disorder in the…

marketbeat.com - Pfizer Inc. (NYSE:PFE) Receives Consensus Recommendation of 'Hold' from Brokerages
Pfizer Inc. (NYSE:PFE) Receives Consensus Recommendation of 'Hold' from Brokerages
MarketBeat

Pfizer Inc. (NYSE:PFE - Get Free Report) has been assigned an average rating of 'Hold' from the twenty-one analysts that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation…

Receive a Daily briefing on Pharma Industry News

Get Started